Characterization of a new TEM-derived beta-lactamase produced in a Serratia marcescens strain

Antimicrob Agents Chemother. 1997 Nov;41(11):2374-82. doi: 10.1128/AAC.41.11.2374.

Abstract

A natural TEM variant beta-lactamase was isolated from an epidemic strain of Serratia marcescens. Nucleotide gene sequencing revealed multiple point mutations located in the 42-to-44 tripeptide and positions 145 to 146, 178, and 238. In addition, a glutamic acid 212 deletion was also found. The purified enzyme was studied from a kinetic point of view, revealing the highest catalytic efficiency (k[cat]/Km) values for ceftazidime and aztreonam compared with the TEM-1 prototype enzyme. The in vitro resistance correlated with kinetic parameters, and the enzyme also mediated resistance to some penicillins and an ampicillin-clavulanic acid combination. The mutational and kinetic changes are discussed in relation to the three-dimensional crystallographic structure of the wild-type TEM-1 enzyme.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Base Sequence
  • Cloning, Molecular
  • Crystallography
  • Drug Resistance, Microbial
  • Kinetics
  • Microbial Sensitivity Tests
  • Molecular Sequence Data
  • Mutation / genetics
  • Penicillins / pharmacology
  • Serratia marcescens / enzymology*
  • beta-Lactamases / chemistry
  • beta-Lactamases / genetics*
  • beta-Lactamases / isolation & purification
  • beta-Lactamases / metabolism

Substances

  • Penicillins
  • beta-Lactamases
  • beta-lactamase TEM-1

Associated data

  • GENBANK/X97254